Fin Milder is professor Biomolecules & Health at the Research Centre Biobased Economy. He focuses on the underlying molecular processes of health and disease.
The core of his research lies in developing biological model systems to determine the impact of biomolecules on living systems in vitro (outside a living organism). In addition, the focus is on the valorization of biobased raw materials, ingredients, and processes for products that enhance the quality of life and bodily functions.
Fin obtained his Master’s degree in molecular sciences from Wageningen University & Research and earned his PhD in structural biology at Utrecht University. He subsequently conducted postdoctoral research in medical microbiology at the University Medical Center Utrecht. Fin continued his career at Janssen Vaccines & Prevention, where he was closely involved as a senior researcher in the discovery and early development activities of new protein-based vaccine candidates for Phase I clinical studies.
The Biomolecules & Health research assignment is part of the Research Centre Biobased Economy and has its roots in the Institute for Life Science & Technology at Hanze University of Applied Sciences.
Contact
Publications-
Fin Milder
Lector Biomolecules & Health
Need more information?
Would you like to know more about the professorship Biomolecules & Health?
Visit the page of the professorship